The Clinical Research Facility has welcomed the first participants on the ELAD Study to the CRF.

The Study is entitled: "Evaluating the effects of the Novel GLP-1 Analogue, Liraglutide, in Patients with Alzheimer's Disease".

To read more about the Study, please visit our Research page here.